Article
Immunologic phenotype of patients with long-COVID syndrome of 1-year duration.
Frontiers in immunology - 1 Jan 2022
García-Abellán Javier, Fernández Marta, Padilla Sergio, García José Alberto, Agulló Vanesa, Lozano Valle, Ena Nuria, García-Sánchez Lidia, Gutiérrez Félix, Masiá Mar
Abstract excerpt
Background: The pathophysiology of long-COVID remains unknown, and information is particularly limited for symptoms of very long duration. We aimed to assess the serological, T-cell immune responses and ANA titers of patients with long-COVID-19 syndrome of 1-year duration. Methods: Prospective, longitudinal study of hospitalized COVID-19 patients followed-up for 12 months. Sequential blood samples and COVID-19...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
